Amphastar Pharma | AMPH | Risky Short?
Amphastar Pharmaceuticals (
AMPH
) is currently at historical resistance after reaching a new high today at $34.42. It's now above the average analyst target ($28.50 as of 3/7/2022) and insiders have sold $2.2 million in the past 2 months. Earnings on March 10th. The float is near 37 million with a 5.5% short interest. It is at "risk" for a squeeze/breakout, but given how extended the play is, there could be a selloff post-earnings. Gap to fill below between $26.20-$26.49. Target 1 is the gap fill / 50 EMA (yellow line).
AMPH
) is currently at historical resistance after reaching a new high today at $34.42. It's now above the average analyst target ($28.50 as of 3/7/2022) and insiders have sold $2.2 million in the past 2 months. Earnings on March 10th. The float is near 37 million with a 5.5% short interest. It is at "risk" for a squeeze/breakout, but given how extended the play is, there could be a selloff post-earnings. Gap to fill below between $26.20-$26.49. Target 1 is the gap fill / 50 EMA (yellow line).
أغلقت الصفقة: تم الوصول لوقف الخسارة:
Earnings beat. Breakout. Failed idea in the near-term. Congrats to the bulls!